(Q37825600)

23 August 2017

1 reference

title

Pharmacological management of type 2 diabetes: the potential of incretin-based therapies (English)

1 reference

23 August 2017

0 references

1 reference

B Charbonnel

1

1 reference

23 August 2017

B Cariou

series ordinal

2

1 reference

23 August 2017

publication date

1 February 2011

1 reference

Diabetes, Obesity and Metabolism

23 August 2017

published in

1 reference

23 August 2017

volume

13

1 reference

23 August 2017

issue

2

1 reference

23 August 2017

page(s)

99-117

1 reference

Individual sulfonylureas and serious hypoglycemia in older people.

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01317.X

Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01317.X

Insulin detemir results in less weight gain than NPH insulin when used in basal-bolus therapy for type 2 diabetes mellitus, and this advantage increases with baseline body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01317.X

The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01317.X

Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01317.X

The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases beta-cell mass in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01317.X

10.1111/J.1463-1326.2010.01317.X

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference